NL8520062A - Bacteriofagen als herkenings- en identificatiemiddelen. - Google Patents
Bacteriofagen als herkenings- en identificatiemiddelen. Download PDFInfo
- Publication number
- NL8520062A NL8520062A NL8520062A NL8520062A NL8520062A NL 8520062 A NL8520062 A NL 8520062A NL 8520062 A NL8520062 A NL 8520062A NL 8520062 A NL8520062 A NL 8520062A NL 8520062 A NL8520062 A NL 8520062A
- Authority
- NL
- Netherlands
- Prior art keywords
- bacteriophage
- bacteria
- molecular
- antibodies
- mutant
- Prior art date
Links
- 241001515965 unidentified phage Species 0.000 title claims description 144
- 241000894006 Bacteria Species 0.000 claims description 103
- 238000000034 method Methods 0.000 claims description 74
- 239000000463 material Substances 0.000 claims description 53
- 210000004027 cell Anatomy 0.000 claims description 44
- 239000003795 chemical substances by application Substances 0.000 claims description 27
- 238000012360 testing method Methods 0.000 claims description 23
- 230000001413 cellular effect Effects 0.000 claims description 22
- 239000012071 phase Substances 0.000 claims description 18
- 230000002285 radioactive effect Effects 0.000 claims description 15
- 239000007790 solid phase Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 230000035772 mutation Effects 0.000 claims description 11
- 108090001090 Lectins Proteins 0.000 claims description 9
- 102000004856 Lectins Human genes 0.000 claims description 9
- 239000002523 lectin Substances 0.000 claims description 9
- 239000013612 plasmid Substances 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 8
- 235000014633 carbohydrates Nutrition 0.000 claims description 8
- 108060003951 Immunoglobulin Proteins 0.000 claims description 7
- 239000000427 antigen Substances 0.000 claims description 7
- 108091007433 antigens Proteins 0.000 claims description 7
- 102000036639 antigens Human genes 0.000 claims description 7
- 102000018358 immunoglobulin Human genes 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 239000007850 fluorescent dye Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 244000052769 pathogen Species 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 5
- 229940072221 immunoglobulins Drugs 0.000 claims description 5
- 239000003086 colorant Substances 0.000 claims description 4
- 230000001575 pathological effect Effects 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000011002 quantification Methods 0.000 claims description 4
- 102000012750 Membrane Glycoproteins Human genes 0.000 claims description 3
- 108010090054 Membrane Glycoproteins Proteins 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 150000002739 metals Chemical class 0.000 claims description 3
- 238000010186 staining Methods 0.000 claims description 3
- 210000004102 animal cell Anatomy 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 230000001678 irradiating effect Effects 0.000 claims 2
- 239000012491 analyte Substances 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000001960 triggered effect Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 description 21
- 108020003175 receptors Proteins 0.000 description 17
- 102000005962 receptors Human genes 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 15
- 239000000725 suspension Substances 0.000 description 14
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 11
- 210000004698 lymphocyte Anatomy 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 10
- 241000588724 Escherichia coli Species 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 241000700605 Viruses Species 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 238000010168 coupling process Methods 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000001188 anti-phage Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000005199 ultracentrifugation Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- 210000004081 cilia Anatomy 0.000 description 4
- 239000007822 coupling agent Substances 0.000 description 4
- 230000009089 cytolysis Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 108700010839 phage proteins Proteins 0.000 description 4
- 239000012857 radioactive material Substances 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 210000001165 lymph node Anatomy 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000003278 mimic effect Effects 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- 241000701533 Escherichia virus T4 Species 0.000 description 2
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 101150117115 V gene Proteins 0.000 description 2
- 108010066342 Virus Receptors Proteins 0.000 description 2
- 102000018265 Virus Receptors Human genes 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000003271 compound fluorescence assay Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- XZTJQQLJJCXOLP-UHFFFAOYSA-M sodium;decyl sulfate Chemical compound [Na+].CCCCCCCCCCOS([O-])(=O)=O XZTJQQLJJCXOLP-UHFFFAOYSA-M 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108700023313 Bacteriophage Receptors Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 230000008265 DNA repair mechanism Effects 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000012745 Immunoglobulin Subunits Human genes 0.000 description 1
- 108010079585 Immunoglobulin Subunits Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000012801 analytical assay Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003302 anti-idiotype Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- -1 erythrocytes Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 210000005104 human peripheral blood lymphocyte Anatomy 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000002764 solid phase assay Methods 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 239000001974 tryptic soy broth Substances 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59113684A | 1984-03-19 | 1984-03-19 | |
| US59113684 | 1984-03-19 | ||
| US8500438 | 1985-03-15 | ||
| PCT/US1985/000438 WO1985004189A1 (en) | 1984-03-19 | 1985-03-15 | Bacteriophages as recognition and identification agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8520062A true NL8520062A (nl) | 1986-02-03 |
Family
ID=24365204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8520062A NL8520062A (nl) | 1984-03-19 | 1985-03-15 | Bacteriofagen als herkenings- en identificatiemiddelen. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0175761A4 (enrdf_load_stackoverflow) |
| JP (1) | JPS61501489A (enrdf_load_stackoverflow) |
| DE (1) | DE3590116T1 (enrdf_load_stackoverflow) |
| GB (1) | GB2181542A (enrdf_load_stackoverflow) |
| NL (1) | NL8520062A (enrdf_load_stackoverflow) |
| SE (1) | SE8505458D0 (enrdf_load_stackoverflow) |
| WO (1) | WO1985004189A1 (enrdf_load_stackoverflow) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4746604A (en) * | 1985-05-24 | 1988-05-24 | Enzo Biochem, Inc. | Specific binding assays utilizing a viable cell as a label |
| WO1988004326A1 (en) * | 1986-12-01 | 1988-06-16 | Mcdonnell Douglas Corporation | Method of identifying unknown organisms |
| EP0439354A3 (en) * | 1990-01-24 | 1992-06-17 | Amoco Corporation | Signal generating moiety and method for use |
| GB9326277D0 (en) * | 1993-12-23 | 1994-02-23 | Marconi Gec Ltd | Labelling |
| JP3270722B2 (ja) * | 1996-09-27 | 2002-04-02 | オルガノ株式会社 | 細菌の検出方法及び検出装置 |
| IT1291913B1 (it) | 1997-05-22 | 1999-01-21 | Angeletti P Ist Richerche Bio | Metodo che prevede l'uso di batteriofagi per la rivelazione della presenza di molecole di interesse in campioni biologici |
| DE69928250T2 (de) * | 1998-06-04 | 2006-08-03 | Microsens Biophage Ltd. | Analytisches verfahren unter verwendung von multipelviren-markierung |
| DE60014987T2 (de) * | 1999-02-22 | 2005-11-10 | Matsushita Electric Industrial Co., Ltd., Kadoma | Verfahren zum Nachweis von Bakterien |
| CA2380480C (en) * | 1999-07-30 | 2010-10-26 | Profos Ag | Detection and identification of bacterial strains |
| US8216780B2 (en) | 2002-04-12 | 2012-07-10 | Microphage (Tm) Incorporated | Method for enhanced sensitivity in bacteriophage-based diagnostic assays |
| WO2003087772A2 (en) | 2002-04-12 | 2003-10-23 | Colorado School Of Mines | Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells |
| US8092990B2 (en) | 2005-03-31 | 2012-01-10 | Colorado School Of Mines | Apparatus and method for detecting microscopic organisms using bacteriophage |
| EP1924701A1 (en) * | 2005-09-15 | 2008-05-28 | Microphage, Incorporated | Method and apparatus for identification of microorganisms using bacteriophage |
| CN101802615A (zh) | 2007-06-15 | 2010-08-11 | 小噬菌体公司 | 利用增强噬菌体扩增来检测微生物的方法 |
| US8697434B2 (en) | 2008-01-11 | 2014-04-15 | Colorado School Of Mines | Detection of phage amplification by SERS nanoparticles |
| US9441204B2 (en) | 2008-04-03 | 2016-09-13 | Colorado School Of Mines | Compositions and methods for detecting Yersinia pestis bacteria |
| FR2940318B1 (fr) * | 2008-12-22 | 2011-05-13 | Centre Nat Rech Scient | Nouveaux biotracteurs et leurs utilisations pour le controle des installations de filtration |
| CN108138218B (zh) * | 2015-07-31 | 2022-10-25 | 联邦高等教育系统匹兹堡大学 | 使用噬菌体的细菌检测 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3094466A (en) * | 1959-07-15 | 1963-06-18 | Warner Lambert Pharmaceutical | Preparation for typing of staphylococci and process therefor |
| US3562384A (en) * | 1960-11-08 | 1971-02-09 | Miles Lab | Immunological indicator and test system |
| US3553310A (en) * | 1967-12-28 | 1971-01-05 | Miles Lab | Immunologically reactive particles |
| GB1303802A (enrdf_load_stackoverflow) * | 1969-01-16 | 1973-01-24 | ||
| US4189466A (en) * | 1975-09-19 | 1980-02-19 | Technical Research Affiliates, Inc. | Detection of rheumatoid factor by antibody sensitized microbial particles |
| US4035316A (en) * | 1975-11-24 | 1977-07-12 | California Institute Of Technology | Cell specific, variable density, polymer microspheres |
| US4104126A (en) * | 1976-01-29 | 1978-08-01 | Nichols Institute Of Endocrinology, Inc. | Non-isotopic substrate assay employing bacteriolysis products |
| US4298689A (en) * | 1978-09-25 | 1981-11-03 | Research Corporation | Gonorrhea diagnostic test |
| US4223005A (en) * | 1979-02-15 | 1980-09-16 | University Of Illinois Foundation | Antibody coated bacteria |
| DE2930706A1 (de) * | 1979-07-28 | 1981-02-05 | Medac Klinische Spezialpraep | Verfahren zum nachweis von erregerspezifischen antikoerpern |
| US4282315A (en) * | 1979-09-13 | 1981-08-04 | Corning Glass Works | Preparation of enriched whole virus radioligand |
| US4474877A (en) * | 1980-09-19 | 1984-10-02 | Research And Education Institute, Inc. Harbor - Ucla Medical Center | Process for detection and measurement of viral specific immunoglobulins and article of manufacture therefor |
| IL63855A (en) * | 1981-09-16 | 1984-10-31 | Teva Pharma | Method and kit for detecting pregnancy |
| US4511662A (en) * | 1982-06-18 | 1985-04-16 | Bio-Rad Laboratories, Inc. | Simultaneous assay for T and B lymphocyte populations and subpopulations |
-
1985
- 1985-03-15 DE DE19853590116 patent/DE3590116T1/de not_active Withdrawn
- 1985-03-15 GB GB08527324A patent/GB2181542A/en not_active Withdrawn
- 1985-03-15 WO PCT/US1985/000438 patent/WO1985004189A1/en not_active Application Discontinuation
- 1985-03-15 NL NL8520062A patent/NL8520062A/nl unknown
- 1985-03-15 JP JP60501412A patent/JPS61501489A/ja active Pending
- 1985-03-15 EP EP19850901766 patent/EP0175761A4/en not_active Withdrawn
- 1985-11-19 SE SE8505458A patent/SE8505458D0/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB8527324D0 (en) | 1985-12-11 |
| EP0175761A4 (en) | 1986-09-24 |
| DE3590116T1 (enrdf_load_stackoverflow) | 1987-02-19 |
| WO1985004189A1 (en) | 1985-09-26 |
| GB2181542A (en) | 1987-04-23 |
| EP0175761A1 (en) | 1986-04-02 |
| SE8505458L (sv) | 1985-11-19 |
| SE8505458D0 (sv) | 1985-11-19 |
| JPS61501489A (ja) | 1986-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4797363A (en) | Bacteriophages as recognition and identification agents | |
| NL8520062A (nl) | Bacteriofagen als herkenings- en identificatiemiddelen. | |
| US20080135490A1 (en) | Quantum dot biolabeling and immunomagnetic separation for detection of contaminants | |
| JP2000513949A (ja) | 生物学的サンプル中における生物学的分子の検出のためのバクテリオファージの使用に基づく方法 | |
| US20100129836A1 (en) | System for detecting bacteria in blood, blood products, and fluids of tissues | |
| US5053054A (en) | Methods and reagents for staining intracellular components | |
| JP5777877B2 (ja) | 血液および組織中の細菌を免疫学的に検出する方法およびキット | |
| US6335173B1 (en) | Methods for detecting an analyte of interest using tyramide coating technology | |
| US6524809B1 (en) | Analytical method using multiple virus labelling | |
| JPWO2001096401A1 (ja) | 蛍光タンパク質を融合したｓｃＦｖ抗体の作製方法 | |
| WO2007065116A2 (en) | Method for detection of antigens | |
| WO2003052144A1 (en) | Diagnostic assays for bcwa | |
| JP4683604B2 (ja) | 内部精度管理法 | |
| DE60125145T2 (de) | Verfahren zur herstellung von biosensoren und ihre anwendung | |
| US7098042B2 (en) | Internal quality control | |
| AU761549B2 (en) | Internal quality control | |
| Chang et al. | Phage display antibodies to allelic determinants of canine blood cells | |
| AU2008202582B2 (en) | Method and kit immuno-detecting bacteria in blood and tissues | |
| Goins | Host defense mechanisms in the crayfish: the effect of injection with live or killed bacteria | |
| Jagani | Flow Cytometry: Basic Principle and Applications in Biotechnology and Pharmacy Hitesh Jagani, 2 Amit Kumar, Sagar S. Gang, Karteek Hebbar, 3 Sahil Talwar. | |
| WO1990015326A1 (en) | Rosette technique for the diagnosis of an active infection | |
| HK1095881B (en) | Biosensors, process for obtaining them and their applications |